152 related articles for article (PubMed ID: 32707441)
21. Arctigenin Attenuates Learning and Memory Deficits through PI3k/Akt/GSK-3β Pathway Reducing Tau Hyperphosphorylation in Aβ-Induced AD Mice.
Qi Y; Dou DQ; Jiang H; Zhang BB; Qin WY; Kang K; Zhang N; Jia D
Planta Med; 2017 Jan; 83(1-02):51-56. PubMed ID: 27224270
[TBL] [Abstract][Full Text] [Related]
22. DL-3-n-butylphthalide inhibits platelet activation via inhibition of cPLA2-mediated TXA2 synthesis and phosphodiesterase.
Ye J; Zhai L; Zhang S; Zhang Y; Chen L; Hu L; Zhang S; Ding Z
Platelets; 2015; 26(8):736-44. PubMed ID: 25734213
[TBL] [Abstract][Full Text] [Related]
23. Guanosine exerts antiplatelet and antithrombotic properties through an adenosine-related cAMP-PKA signaling.
Fuentes F; Alarcón M; Badimon L; Fuentes M; Klotz KN; Vilahur G; Kachler S; Padró T; Palomo I; Fuentes E
Int J Cardiol; 2017 Dec; 248():294-300. PubMed ID: 28811090
[TBL] [Abstract][Full Text] [Related]
24. Antiplatelet Activity of a Newly Synthesized Novel Ruthenium (II): A Potential Role for Akt/JNK Signaling.
Khamrang T; Hung KC; Hsia CH; Hsieh CY; Velusamy M; Jayakumar T; Sheu JR
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28448438
[TBL] [Abstract][Full Text] [Related]
25. PDK1 selectively phosphorylates Thr(308) on Akt and contributes to human platelet functional responses.
Dangelmaier C; Manne BK; Liverani E; Jin J; Bray P; Kunapuli SP
Thromb Haemost; 2014 Mar; 111(3):508-17. PubMed ID: 24352480
[TBL] [Abstract][Full Text] [Related]
26. Modulation of human platelet activation and in vivo vascular thrombosis by columbianadin: regulation by integrin α
Hou SM; Hsia CW; Tsai CL; Hsia CH; Jayakumar T; Velusamy M; Sheu JR
J Biomed Sci; 2020 May; 27(1):60. PubMed ID: 32375785
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effect of caffeic acid on ADP-induced thrombus formation and platelet activation involves mitogen-activated protein kinases.
Lu Y; Li Q; Liu YY; Sun K; Fan JY; Wang CS; Han JY
Sci Rep; 2015 Sep; 5():13824. PubMed ID: 26345207
[TBL] [Abstract][Full Text] [Related]
28. The antiplatelet activity of magnolol is mediated by PPAR-β/γ.
Shih CY; Chou TC
Biochem Pharmacol; 2012 Sep; 84(6):793-803. PubMed ID: 22750553
[TBL] [Abstract][Full Text] [Related]
29. Anti-Thrombotic Effects of Artesunate through Regulation of cAMP and PI3K/MAPK Pathway on Human Platelets.
Yoon SS; Kwon HW; Shin JH; Rhee MH; Park CE; Lee DH
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163507
[TBL] [Abstract][Full Text] [Related]
30. Thromboxane A2 synthase inhibition and thromboxane A2 receptor blockade by 2-[(4-cyanophenyl)amino]-3-chloro-1,4-naphthalenedione (NQ-Y15) in rat platelets.
Chang TS; Kim HM; Lee KS; Khil LY; Mar WC; Ryu CK; Moon CK
Biochem Pharmacol; 1997 Jul; 54(2):259-68. PubMed ID: 9271330
[TBL] [Abstract][Full Text] [Related]
31. Timosaponin AIII induces antiplatelet and antithrombotic activity via Gq-mediated signaling by the thromboxane A2 receptor.
Cong Y; Wang L; Peng R; Zhao Y; Bai F; Yang C; Liu X; Wang D; Ma B; Cong Y
Sci Rep; 2016 Dec; 6():38757. PubMed ID: 27934923
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
Yu SM; Wu TS; Teng CM
Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
[TBL] [Abstract][Full Text] [Related]
33. SDF-1α is a novel autocrine activator of platelets operating through its receptor CXCR4.
Walsh TG; Harper MT; Poole AW
Cell Signal; 2015 Jan; 27(1):37-46. PubMed ID: 25283599
[TBL] [Abstract][Full Text] [Related]
34. Ask1 regulates murine platelet granule secretion, thromboxane A
Naik MU; Patel P; Derstine R; Turaga R; Chen X; Golla K; Neeves KB; Ichijo H; Naik UP
Blood; 2017 Mar; 129(9):1197-1209. PubMed ID: 28028021
[TBL] [Abstract][Full Text] [Related]
35. The novel prostaglandin I2 mimetic ONO-1301 escapes desensitization in an antiplatelet effect due to its inhibitory action on thromboxane A2 synthesis in mice.
Kashiwagi H; Yuhki K; Kojima F; Kumei S; Takahata O; Sakai Y; Narumiya S; Ushikubi F
J Pharmacol Exp Ther; 2015 May; 353(2):269-78. PubMed ID: 25740898
[TBL] [Abstract][Full Text] [Related]
36. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
Aoki T; Tomiyama Y; Honda S; Senzaki K; Tanaka A; Okubo M; Takahashi F; Takasugi H; Seki J
Thromb Haemost; 1998 Jun; 79(6):1184-90. PubMed ID: 9657446
[TBL] [Abstract][Full Text] [Related]
37. 3,4-Dihydroquinolin-2(1H)-ones as combined inhibitors of thromboxane A2 synthase and cAMP phosphodiesterase.
Martinez GR; Walker KA; Hirschfeld DR; Bruno JJ; Yang DS; Maloney PJ
J Med Chem; 1992 Feb; 35(4):620-8. PubMed ID: 1311763
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms of satigrel (E5510), a new anti-platelet drug, in inhibiting human platelet aggregation. Selectivity and potency against prostaglandin H synthases isozyme activities and phosphodiesterase isoform activities.
Nagakura N; Saeki T; Harada K; Yoshitake S; Kobayashi S; Yamanaka T; Saito I
Biol Pharm Bull; 1996 Jun; 19(6):828-33. PubMed ID: 8799481
[TBL] [Abstract][Full Text] [Related]
39. Tumor vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid inhibits platelet activation and thrombosis via inhibition of thromboxane A2 signaling and phosphodiesterase.
Zhang SH; Zhang Y; Shen J; Zhang S; Chen L; Gu J; Mruk JS; Cheng G; Zhu L; Kunapuli SP; Ding Z
J Thromb Haemost; 2013 Oct; 11(10):1855-66. PubMed ID: 23902231
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological actions of miltirone in the modulation of platelet function.
Song W; Ma YY; Miao S; Yang RP; Zhu Y; Shu D; Lu M; Ma R; Ming ZY
Acta Pharmacol Sin; 2019 Feb; 40(2):199-207. PubMed ID: 29795134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
